Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000482258 | SCV000573202 | likely benign | not provided | 2020-11-20 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000862700 | SCV001003241 | likely benign | Developmental and epileptic encephalopathy, 36 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002431416 | SCV002740830 | likely benign | Inborn genetic diseases | 2018-03-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000862700 | SCV003826154 | uncertain significance | Developmental and epileptic encephalopathy, 36 | 2021-04-19 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000482258 | SCV001930254 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000482258 | SCV001973248 | likely benign | not provided | no assertion criteria provided | clinical testing |